Literature DB >> 19630151

Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA.

.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19630151

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  10 in total

1.  Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine.

Authors:  Clifford L Cua; Lynette K Rogers; Louis G Chicoine; Molly Augustine; Yi Jin; Patricia L Nash; Leif D Nelin
Journal:  Eur J Pediatr       Date:  2010-12-01       Impact factor: 3.183

2.  [Lung diseases - pulmonary hypertension].

Authors:  B E Strauer; B Zabel
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

3.  An official American Thoracic Society Statement: pulmonary hypertension phenotypes.

Authors:  Raed A Dweik; Sharon Rounds; Serpil C Erzurum; Stephen Archer; Karen Fagan; Paul M Hassoun; Nicholas S Hill; Marc Humbert; Steven M Kawut; Michael Krowka; Evangelos Michelakis; Nicholas W Morrell; Kurt Stenmark; Rubin M Tuder; John Newman
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

4.  Noninvasive model including right ventricular speckle tracking for the evaluation of pulmonary hypertension.

Authors:  Yossra Mahran; Robert Schueler; Marcel Weber; Carmen Pizarro; Georg Nickenig; Dirk Skowasch; Christoph Hammerstingl
Journal:  World J Cardiol       Date:  2016-08-26

5.  Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.

Authors:  Chun Zhou; Edward S Crockett; Lynn Batten; Ivan F McMurtry; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

6.  Diagnostic value of echocardiography in the diagnosis of pulmonary hypertension.

Authors:  Christoph Hammerstingl; Robert Schueler; Lisa Bors; Diana Momcilovic; Stefan Pabst; Georg Nickenig; Dirk Skowasch
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

7.  Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease.

Authors:  Kelley L Colvin; Michael E Yeager
Journal:  J Pulm Respir Med       Date:  2014-08-04

8.  In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans.

Authors:  Monika Szturmowicz; Aneta Kacprzak; Barbara Burakowska; Marcin Kurzyna; Anna Fijałkowska; Iwona Bestry; Adam Torbicki
Journal:  Multidiscip Respir Med       Date:  2010-12-20

9.  Clinical variability of respiratory pulmonary hypertension: implications for diagnosis and management.

Authors:  Lucio Casali; Pierluigi Carratù; Matteo Sofia
Journal:  Multidiscip Respir Med       Date:  2013-11-26

10.  A translational preclinical model of interstitial pulmonary fibrosis and pulmonary hypertension: mechanistic pathways driving disease pathophysiology.

Authors:  Elizabeth R Jarman; Valerie S Khambata; Li Yun Ye; Kenneth Cheung; Matthew Thomas; Nicholas Duggan; Gabor Jarai
Journal:  Physiol Rep       Date:  2014-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.